Please login to the form below

Not currently logged in

Covance to collaborate with Indiana University on trials

Will work with the US university on pharma and biotech studies

Clinical research organisation (CRO) Covance is to work with the Indiana Clinical and Translational Sciences Institute (CTSI) on early-stage clinical trials for its pharma and biotech clients.

Part of Indiana University's School of Medicine, CTSI will collaborate with the CRO on first-in-man and phase I trials.

Covance said the agreement would provide a significant opportunity to bring more phase I clinical studies to Indiana, combining CTSI's capabilities in Indianapolis and those of its own Evansville clinical research unit.

Rob Aspbury, vice president and general manager, global clinical pharmacology services at Covance, said: “The alliance with the Indiana CTSI will help us provide biopharmaceutical clients with quicker access to patients in a hospital setting that supports specialised care and monitoring.

“With quicker access to patients, we can streamline the drug development process and bring important new medications to patients who need them.”

The Indiana CTSI is a state-wide collaboration of Indiana University, Purdue University and the University of Notre Dame that aims to help translate scientific discoveries into new patient treatments.

It will provide Covance with access to a 24-patient facility at IU Health University Hospital in Indianapolis and may expand operations into a recently renovated 50-patient facility in the same building.  

Anantha Shekhar, director of the Indiana CTSI, said: “Our mission is to accelerate the rate at which this research travels out of the lab and into the care of the patients who need it.  This alliance with Covance will greatly enhance our ability to accomplish this vital work.”

Article by
Dominic Tyer

16th September 2013

From: Research



Related Hub content

Featured jobs

Subscribe to our email news alerts


Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...